Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)
China
· Delayed Price · Currency is CNY 7.06
-0.01 (-0.14%)
Mar 11, 2026, 3:00 PM CST
SHA:605199 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 10, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Market Capitalization | 2,829 | 6,374 | 6,066 | 6,410 | 9,971 | 9,651 | Upgrade
|
| Market Cap Growth | -60.41% | 5.08% | -5.37% | -35.71% | 3.32% | - | Upgrade
|
| Enterprise Value | 4,080 | 7,596 | 7,039 | 6,749 | 10,111 | 9,721 | Upgrade
|
| Last Close Price | 7.07 | 15.93 | 14.97 | 15.82 | 24.60 | 23.69 | Upgrade
|
| PE Ratio | - | - | 558.97 | 74.81 | 138.22 | 79.43 | Upgrade
|
| PS Ratio | 2.66 | 4.51 | 3.38 | 4.23 | 7.37 | 8.31 | Upgrade
|
| PB Ratio | 3.85 | 8.57 | 5.70 | 6.31 | 10.72 | 10.53 | Upgrade
|
| P/TBV Ratio | 5.86 | 12.59 | 7.11 | 7.03 | 12.25 | 12.19 | Upgrade
|
| P/OCF Ratio | 24.75 | - | 214.70 | 26.85 | 97.29 | 2924.53 | Upgrade
|
| EV/Sales Ratio | 3.84 | 5.37 | 3.92 | 4.45 | 7.47 | 8.37 | Upgrade
|
| EV/EBITDA Ratio | - | - | 94.98 | 46.94 | 86.08 | 67.48 | Upgrade
|
| EV/EBIT Ratio | - | - | 323.73 | 69.20 | 139.08 | 96.68 | Upgrade
|
| Debt / Equity Ratio | 1.79 | 1.88 | 1.21 | 0.67 | 0.54 | 0.31 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 15.90 | 4.60 | 4.13 | 1.96 | Upgrade
|
| Debt / FCF Ratio | 44.97 | - | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 1.64 | 1.54 | 0.71 | 0.20 | 0.01 | -0.07 | Upgrade
|
| Net Debt / EBITDA Ratio | -23.01 | -5.58 | 10.24 | 1.42 | 0.10 | -0.44 | Upgrade
|
| Net Debt / FCF Ratio | 41.19 | -3.75 | -1.65 | -1.33 | -0.33 | 1.12 | Upgrade
|
| Asset Turnover | 0.36 | 0.48 | 0.68 | 0.74 | 0.83 | 0.89 | Upgrade
|
| Inventory Turnover | 1.79 | 2.05 | 3.61 | 3.02 | 2.74 | 2.64 | Upgrade
|
| Quick Ratio | 0.47 | 0.47 | 0.95 | 0.89 | 1.07 | 1.40 | Upgrade
|
| Current Ratio | 0.82 | 0.85 | 1.27 | 1.18 | 1.37 | 1.76 | Upgrade
|
| Return on Equity (ROE) | -16.95% | -29.83% | 1.63% | 8.71% | 7.53% | 15.57% | Upgrade
|
| Return on Assets (ROA) | -2.99% | -5.89% | 0.52% | 2.99% | 2.77% | 4.82% | Upgrade
|
| Return on Invested Capital (ROIC) | -7.24% | -15.00% | 0.90% | 7.87% | 6.90% | 12.01% | Upgrade
|
| Return on Capital Employed (ROCE) | -9.50% | -18.20% | 1.20% | 7.80% | 7.50% | 10.30% | Upgrade
|
| Earnings Yield | -5.94% | -4.31% | 0.18% | 1.34% | 0.72% | 1.26% | Upgrade
|
| FCF Yield | 1.03% | -4.79% | -7.60% | -2.40% | -0.35% | -0.58% | Upgrade
|
| Dividend Yield | - | - | 0.83% | - | - | 0.63% | Upgrade
|
| Payout Ratio | - | - | 290.87% | 16.75% | 102.23% | 6.58% | Upgrade
|
| Buyback Yield / Dilution | -3.98% | -9.97% | 11.35% | -1.81% | -5.55% | -4.13% | Upgrade
|
| Total Shareholder Return | -3.98% | -9.97% | 12.18% | -1.81% | -5.55% | -3.50% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.